Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine

Pediatric Infectious Disease Journal

Volumn 33, Issue 1, 2014, Pages 81-83

  Antachopoulos, Charalampos ^a   Tsolia, Maria N ^b   Tzanakaki, Georgina ^c   Xirogianni, Athanasia ^c   Dedousi, Olga ^b   Markou, Georgia ^d   Zografou, Sofia Maria ^d   Eliades, Andreas ^d   Kirvassilis, Fotis ^a   Kesanopoulos, Konstantinos ^c   Roilides, Emmanuel ^a  

^a Aristotle University and Hippokration General Hospital   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^d UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

13 Valent Conjugated Pneumococcal Vaccine; Parapneumonic Pleural Effusion; Serotype 3; Streptococcus Pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ARTICLE; BACTERIAL STRAIN; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GREECE; HUMAN; IMMUNIZATION; MALE; PARAPNEUMONIC PLEURAL EFFUSION; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX DRAINAGE;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; MALE; PLEURAL EFFUSION; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 84891538905     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000041     Document Type: Article

References (10)

1. Resti M, Moriondo M, Cortimiglia M, et al.; Italian Group for the Study of Invasive Pneumococcal Disease. Community-acquired bacteremic pneumococcal pneumonia in children: Diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis. 2010;51: 1042-1049
2. Gruber WC, Scott DA, Emini EA. Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine. Ann N Y Acad Sci. 2012;1263:15-26
3. Kremastinou J, Tzanakaki G. Apologismos EKAM 2011. Available at: Http://www.nsph.gr/files/001-Dimosias-Dioikitikis-Ygieinis/EKAM/ ApologismoiEKAM/Apologismos-EKAM-2011.pdf. Accessed June 8, 2013
4. T zanakaki G, Tsopanomichalou M, Kesanopoulos K, et al. Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae. Clin Microbiol Infect. 2005;11:386-390
5. Xirogianni A, Tsolia M, Voyiatzi A, et al. Diagnosis of upper and lower respiratory tract bacterial infections with the use of multiplex PCR assays. Diagnostics. 2013;3:222-231
6. Yeh SH, Gurtman A, Hurley DC, et al.; 004 Study Group. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers. Pediatrics. 2010;126:e493-e505
7. Kieninger DM, Kueper K, Steul K, et al.; 006 study group. Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany. Vaccine. 2010;28:4192-4203
8. S nape MD, Klinger CL, Daniels ED, et al. Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: A double-blind randomized active-controlled trial. Pediatr Infect Dis J. 2010;29:e80-e90
9. E sposito S, Tansey S, Thompson A, et al. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers. Clin Vaccine Immunol. 2010;17:1017-1026
10. Frenck R Jr, Thompson A, Yeh SH, et al.; 3011 Study Group. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2011;30:1086-1091